Drug Shortage Report for TEVA-BETAHISTINE

Last updated on 2022-05-21 History
Report ID 160989
Drug Identification Number 02280191
Brand name TEVA-BETAHISTINE
Common or Proper name BETAHISTINE 16MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) BETAHISTINE HYDROCHLORIDE
Strength(s) 16MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code N07CA
ATC description ANTIVERTIGO PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-03-18
Estimated end date 2022-07-31
Actual end date 2022-05-20
Shortage status Resolved
Updated date 2022-05-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-05-21 English Compare
v4 2022-05-20 French Compare
v3 2022-05-20 English Compare
v2 2022-05-19 French Compare
v1 2022-05-19 English Compare

Showing 1 to 5 of 5